Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Orlova KV, Ledin EV, Zhukova NV, Orlova RV, Karabina EV, Volkonskiy MV, Stroyakovskiy DL, Yurchenkov AN, Protsenko SA, Novik AV, Vorotilina LV, Moiseenko FV, Chang VL, Kazmin AI, Tkachenko SA, Gamaunov SV, Naskhletashvili DR, Samoylenko IV, Vikhrova AS, Utyashev IA, Kharkevich GY, Petenko NN, Shubina IZ, Demidov LV. Orlova KV, et al. Among authors: utyashev ia. Cancers (Basel). 2021 May 21;13(11):2529. doi: 10.3390/cancers13112529. Cancers (Basel). 2021. PMID: 34064013 Free PMC article.
Cancer/testis genes expression in human melanoma cell lines.
Mikhaylova IN, Kovalevsky DA, Morozova LF, Golubeva VA, Cheremushkin EA, Lukashina MI, Voronina ES, Burova OS, Utyashev IA, Kiselev SL, Demidov LV, Beabealashvilli RSh, Baryshnikov AY. Mikhaylova IN, et al. Among authors: utyashev ia. Melanoma Res. 2008 Oct;18(5):303-13. doi: 10.1097/CMR.0b013e32830e391d. Melanoma Res. 2008. PMID: 18781128
Melanoma arising in a Giant congenital melanocytic nevus: two case reports.
Belysheva TS, Vishnevskaya YV, Nasedkina TV, Emelyanova MA, Abramov IS, Orlova KV, Lubchenko LN, Utyashev IA, Doroshenko MB, Demidov LV, Aliev MD. Belysheva TS, et al. Among authors: utyashev ia. Diagn Pathol. 2019 Feb 19;14(1):21. doi: 10.1186/s13000-019-0797-1. Diagn Pathol. 2019. PMID: 30782194 Free PMC article.
A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer.
Tsimafeyeu I, Statsenko G, Vladimirova L, Besova N, Artamonova E, Raskin G, Rykov I, Mochalova A, Utyashev I, Gorbacheva S, Kazey V, Gavrilova E, Dragun N, Moiseyenko V, Tjulandin S. Tsimafeyeu I, et al. Invest New Drugs. 2023 Apr;41(2):324-332. doi: 10.1007/s10637-023-01340-z. Epub 2023 Mar 13. Invest New Drugs. 2023. PMID: 36907947 Clinical Trial.
Analysis of circulating tumor cells in patients with triple negative breast cancer during preoperative chemotherapy.
Lavrov AV, Zubtsova ZhI, Zubtsov DA, Frolova MA, Ignatova EO, Skrypnikova MA, Malysheva EV, Legchenko EV, Petrovskii AV, Utyashev IA, Tyulyandin SA, Gol'dshtein DV. Lavrov AV, et al. Among authors: utyashev ia. Bull Exp Biol Med. 2014 May;157(1):159-61. doi: 10.1007/s10517-014-2514-0. Epub 2014 Jun 11. Bull Exp Biol Med. 2014. PMID: 24913582
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.
Choueiri TK, Powles T, Peltola K, de Velasco G, Burotto M, Suarez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E, Gümüş M, Stadler WM, Kollmannsberger C, Melichar B, Venugopal B, Gross-Goupil M, Poprach A, De Santis M, Schutz FA, Park SH, Nosov DA, Porta C, Lee JL, Garcia-Del-Muro X, Biscaldi E, Manneh Kopp R, Oya M, He L, Wang A, Perini RF, Vickery D, Albiges L, Rini B; LITESPARK-005 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Aug 22;391(8):710-721. doi: 10.1056/NEJMoa2313906. N Engl J Med. 2024. PMID: 39167807 Clinical Trial.
Intrapleural nivolumab in cancer patients with pleural effusion.
Tsimafeyeu I, Goutnik V, Shrainer I, Kosyrev V, Bondarenko A, Utyashev I. Tsimafeyeu I, et al. J Cancer Res Ther. 2024 Apr 1;20(3):1036-1038. doi: 10.4103/jcrt.jcrt_739_22. Epub 2023 Apr 6. J Cancer Res Ther. 2024. PMID: 39023613 Free article.
Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study.
Samoylenko IV, Kolontareva YM, Kogay EV, Zhukova NV, Utyashev IA, Ivannikov ME, Menshikov KV, Zinkevich MV, Orlova KV, Vakhabova YV, Volkonsky MV, Beliaeva NA, Butkov II, Karabina EV, Moskovkina TL, Moshkova KA, Plishkina OV, Sychev VD, Cheplukhova OS, Chernova VV, Yurchenkov AN, Babina KG, Savelov NA, Demidov LV. Samoylenko IV, et al. Among authors: utyashev ia. Front Oncol. 2024 Oct 14;14:1395378. doi: 10.3389/fonc.2024.1395378. eCollection 2024. Front Oncol. 2024. PMID: 39469641 Free PMC article.